SOFGARDLA Trademark

Trademark Overview

On Friday, December 6, 2019, a trademark application was filed for SOFGARDLA with the United States Patent and Trademark Office. The USPTO has given the SOFGARDLA trademark a serial number of 88718360. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, January 9, 2023. This trademark is owned by Shire ViroPharma Incorporated. The SOFGARDLA trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical products, namely, budesonide oral suspension (BOS) for eosinophilic esophagitis (EoE)
sofgardla

General Information

Serial Number88718360
Word MarkSOFGARDLA
Filing DateFriday, December 6, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, January 9, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 14, 2020

Trademark Statements

Goods and Servicespharmaceutical products, namely, budesonide oral suspension (BOS) for eosinophilic esophagitis (EoE)

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, December 11, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameVIROPHARMA BIOLOGICS LLC
Party Type22 - New Owner After Publication
Legal Entity Type16 - Limited Liability Company
AddressLEXINGTON, MA 02421
Party NameSHIRE VIROPHARMA LLC
Party Type21 - New Owner After Publication
Legal Entity Type16 - Limited Liability Company
AddressLexington, MA 02421
Party NameShire ViroPharma Incorporated
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressLexington, MA 02421
Party NameShire ViroPharma Incorporated
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLexington, MA 02421

Trademark Events

Event DateEvent Description
Monday, January 9, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, January 9, 2023ABANDONMENT - NO USE STATEMENT FILED
Wednesday, December 15, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 13, 2021SOU EXTENSION 4 GRANTED
Monday, December 13, 2021SOU EXTENSION 4 FILED
Monday, December 13, 2021SOU TEAS EXTENSION RECEIVED
Wednesday, September 22, 2021AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, September 14, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, September 10, 2021SOU EXTENSION 3 GRANTED
Friday, September 10, 2021SOU EXTENSION 3 FILED
Friday, September 10, 2021SOU TEAS EXTENSION RECEIVED
Wednesday, March 24, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 22, 2021SOU EXTENSION 2 GRANTED
Monday, March 22, 2021SOU EXTENSION 2 FILED
Monday, March 22, 2021SOU TEAS EXTENSION RECEIVED
Saturday, October 31, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 29, 2020SOU EXTENSION 1 GRANTED
Thursday, October 29, 2020SOU EXTENSION 1 FILED
Thursday, October 29, 2020SOU TEAS EXTENSION RECEIVED
Tuesday, July 7, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, July 7, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, July 7, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, July 7, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, July 7, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, June 9, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, April 15, 2020AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, April 14, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 14, 2020PUBLISHED FOR OPPOSITION
Wednesday, March 25, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 10, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, March 7, 2020ASSIGNED TO EXAMINER
Wednesday, December 11, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, December 10, 2019NEW APPLICATION ENTERED

Related Keywords

sofgardla suspension eosinophilic esophagitis oral budesonide products namely pharmaceutical